CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

CompletedOBSERVATIONAL
Enrollment

851

Participants

Timeline

Start Date

February 1, 2010

Primary Completion Date

June 28, 2023

Study Completion Date

June 28, 2023

Conditions
Metastatic Nonsmall Cell Lung Cancer
Interventions
DRUG

Pembrolizumab

DRUG

Pemetrexed

DRUG

Cisplatin

DRUG

Carboplatin

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

collaborator

Amgen

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Bayer

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Janssen, LP

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

Aetion, Inc.

OTHER